About Zetta Genomics
Zetta Genomics is a company based in Worcester (United Kingdom) founded in 2018 by Ignacio Medina. Zetta Genomics has raised $10.39 million across 3 funding rounds from investors including Werfen, University of Cambridge and We Venture Capital. The company has 4 employees as of July 31, 2021. Zetta Genomics offers products and services including XetaBase. Zetta Genomics operates in a competitive market with competitors including DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
- Headquarter Worcester, United Kingdom
- Employees 4 as on 31 Jul, 2021
- Founders Ignacio Medina
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zetta Genomics Limited
- Date of Incorporation 20 Jul, 2018
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
-$87.27 K (USD)-372as on Jul 31, 2021
-
EBITDA
Not available
-
Total Equity Funding
$10.39 M (USD)
in 3 rounds
-
Latest Funding Round
$4.63 M (USD), Seed
Feb 08, 2024
-
Investors
Werfen
& 4 more
-
Employee Count
4
as on Jul 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zetta Genomics
Zetta Genomics offers a comprehensive portfolio of products and services, including XetaBase.
Platform for efficient genomic data management and analysis.
People of Zetta Genomics
Unlock access to complete
Funding Insights of Zetta Genomics
Zetta Genomics has successfully raised a total of $10.39M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $4.63 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Zetta Genomics
Zetta Genomics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Werfen, University of Cambridge and We Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on diagnostics start-ups and digital solutions.
|
Locked | Locked | Locked | |
|
Venture capital funding is offered for deep-tech and medical startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Zetta Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zetta Genomics
Investment portfolio details for Zetta Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zetta Genomics
Detailed financials for Zetta Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zetta Genomics Comparisons
Peer comparison for Zetta Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zetta Genomics
Zetta Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
DNA sequencing technology is developed to detect genomic mutations.
|
Detailed competitors of Zetta Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zetta Genomics
Complete news archive for Zetta Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zetta Genomics
Zetta Genomics was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Zetta Genomics is headquartered in Worcester, United Kingdom. It is registered at Worcester, Worcestershire, United Kingdom.
Paul Agnew is the current CEO of Zetta Genomics.
Zetta Genomics is a funded company, having raised a total of $10.39M across 3 funding rounds to date.
As of Jul 31, 2021, the latest employee count at Zetta Genomics is 4.
Zetta Genomics was founded in 2018 and is headquartered in Worcester, United Kingdom. Operations focus on the biotechnology sector, where computational tools are developed for analyzing genomic data. These tools are utilized by clinical laboratories and research organizations to process and interpret genetic information. Services encompass software solutions tailored for genomic workflows, supporting data-driven insights in healthcare and scientific research.
Zetta Genomics's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Zetta Genomics offers XetaBase.
Zetta Genomics has 5 investors. Key investors include Werfen, University of Cambridge, We Venture Capital, APEX Ventures, and Nina Capital.